key: cord-0797368-7dsonywl authors: Nogara, Pablo Andrei; Orian, Laura; Rocha, João Batista Teixeira title: The Se S/N interactions as a possible mechanism of δ-aminolevulinic acid dehydratase enzyme inhibition by organoselenium compounds: a computational study date: 2020-06-09 journal: Comput Toxicol DOI: 10.1016/j.comtox.2020.100127 sha: 1797627b3f7f8daa5ef09fd1afa0873b5287cb24 doc_id: 797368 cord_uid: 7dsonywl Organoselenium compounds present many pharmacological properties and are promising drugs. However, toxicological effects associated with inhibition of thiol-containing enzymes, such as the δ-aminolevulinic acid dehydratase (δ-AlaD), have been described. The molecular mechanism(s) by which they inhibit thiol-containing enzymes at the atomic level, is still not well known. The use of computational methods to understand the physical-chemical properties and biological activity of chemicals is essential to the rational design of new drugs. In this work, we propose an in silico study to understand the δ-AlaD inhibition mechanism by diphenyl diselenide (DPDS) and its putative metabolite, phenylseleninic acid (PSA), using δ-AlaD enzymes from Homo sapiens (Hsδ-AlaD), Drosophila melanogaster (Dmδ-AlaD) and Cucumis sativus (Csδ-AlaD). Protein modeling homology, molecular docking, and DFT calculations are combined in this study. According to the molecular docking, DPDS and PSA might bind in the Hsδ-AlaD and Dmδ-AlaD active sites interacting with the cysteine residues by Se(…)S interactions. On the other hand, the DPDS does not access the active site of the Csδ-AlaD (a non-thiol protein), while the PSA interacts with the amino acids residues from the active site, such as the Lys291. These interactions might lead to the formation of a covalent bond, and consequently, to the enzyme inhibition. In fact, DFT calculations (mPW1PW91/def2TZVP) demonstrated that the selenylamide bond formation is energetically favored. The in silico data showed here are in accordance with previous experimental studies, and help us to understand the reactivity and biological activity of organoselenium compounds. catalases), and chlorophyll synthesis [13, [15] [16] [17] . There are two major classes of δ-AlaD: the 23 Zn-dependent enzymes (that are present in mammals, fungi and some bacteria, such as 24 Escherichia coli) [15, 18, 19] , and the Mg-dependent enzymes, that are found mainly in plants, 25 protozoa and other bacteria [13, [20] [21] [22] . 26 Studies have demonstrated that the DPDS can inhibit the δ-AlaD enzyme from human 27 (Hsδ-AlaD) and rodents [10, 11, [23] [24] [25] [26] [27] [28] . The δ-AlaD from Drosophila melanogaster (Dmδ- 28 AlaD) can also be inhibited by DPDS [29] . In contrast, DPDS do not inhibit δ-AlaD from 29 cucumber, Cucumis sativus (Csδ-AlaD); nevertheless, its putative metabolite, the 30 phenylseleninic acid (PSA), can inhibit the Csδ-AlaD [30] . In fact, the toxicity of 31 organoselenium compounds could be associated with their metabolic oxidation by flavin- 1 containing monooxygenases [4, 31, 32] . However, the inhibition mechanism(s) involved in these 2 cases has not been established yet. 3 To complement and better understand the in vivo and in vitro data, in silico methods 4 have been used to analyze, simulate, and predict the pharmacology and toxicity of chemicals 5 [33-37]. There are many types of computational methods, where the molecular docking stands 6 out by simulating the interactions between macromolecules (proteins and DNA) and ligands 7 (substrate, inhibitor, and agonist). This method consists in predicting the binding mode of the 8 ligand at the binding site of a given target, in addition to the estimation of affinity for the 9 receptor, by predicting binding free energy (ΔG) [38] [39] [40] [41] . Quantum mechanical methods, such 10 as the density functional theory (DFT) approach, are frequently used in the study of structures, 11 reactions, and molecular properties [42] [43] [44] , but are strictly limited to systems of few hundreds 12 of atoms. In addition, the protein homology modeling has been successfully employed to predict 13 the 3D protein structure, which is essential in many cases when the tertiary or quaternary 14 structure must be studied [45] [46] [47] [48] [49] . 15 Different in silico methods have been adopted to predict the reactivity, toxicity, and 16 pharmacology of organoselenium compounds and selenoproteins [44, [50] [51] [52] [53] [54] [55] [56] [57] [58] . Here, to better 17 understand the toxicological effects of organoselenium molecules, and how they interact with 18 target proteins, we propose an in silico approach combining protein homology modeling, 19 molecular docking simulations, and DFT calculations (Scheme 1). Based on the difference of 20 DPDS and PSA inhibition behavior on δ-AlaD enzymes, this study aims to compare the 21 intermolecular interactions between the Hsδ-AlaD, Dmδ-AlaD and Csδ-AlaD enzymes and the 22 DPDS and PSA organoselenium compounds, to gain insight into their mechanisms of inhibition. 31 and Wolbachia) were performed. The FASTA amino acid sequences for δ-AlaD enzymes were 1 obtained from the the National Center for Biotechnology Information -NCBI 2 (https://www.ncbi.nlm.nih.gov/pubmed/), UniProt (http://www.uniprot.org/) and Protein Data (http://www.ebi.ac.uk/Tools/msa/clustalo) was used to make the multiple sequence alignment, 14 and the similarity between the δ-AlaD sequences was calculated from the Geneious program 15 (https://www.geneious.com) (Figure 2 , S1, S2 and Table S1 ). 16 Since there is no available three-dimensional structure of Dmδ-AlaD and Csδ-AlaD, the Considering that DPDS inhibits the Hsδ-AlaD [11] and Dmδ-AlaD [29] and does not Group B, which includes the species that have Asp residues (Toxoplasma gondii, Cucumis 15 sativus, Wolbachia, Pseudomonas aeruginosa and Chlorobaculum parvum) ( Figure S2 ). 16 Interestingly, the Blattella germanica δ-AlaD is small when compared to the other species (146 17 vs ~330 residues) and has not the Cys region of the active site; however, the catalytic Lys 18 residues are conserved ( Figure S1 ). According to the phylogenetic tree ( Figure S2 ) it belongs 19 to Group A. 20 In general, the three cysteine residues from the active site of Group A δ-AlaD were 21 replaced by two aspartate residues and one alanine residue in Group B (Figure 2 and studies of Kervinen et al. (2001) [86] where five δ-AlaD enzymes (from Pisum sativum, 27 Pseudomonas aeruginosa, Bradyrhizobium japonicum, Escherichia coli, and H. sapiens) 28 sequences were analysed, and the metal-binding region determined. 29 Here, based on these observations, we can suppose that DPDS does not inhibit the Csδ- 30 AlaD because this enzyme does not present Cys residues in its active site. However, it does not 31 explain why PSA inhibits the Csδ-AlaD. For a better understanding of the interactions between 1 inhibitors and enzymes, the molecular docking simulations were performed. Taking into 2 account that there are no Csδ-AlaD and Dmδ-AlaD structures available, the 3D model of these 3 enzymes were built using protein homology modelling. 4 Homology modeling is the most accurate method to build protein structure models [87- 14 According to the data in Table S2 and S3, the best Dmδ-AlaD and Csδ-AlaD models 15 were obtained from the PDB ID 1L6S and PDB ID 3OBK templates, respectively, using the 16 Swiss-Model program, which turned out to be the most performant program for this task. Dmδ- 17 AlaD-1L6S and Csδ-AlaD-3OBK models showed a satisfactory protein structure, because the 18 validation parameters are in the range of native protein structure (see the Supporting 19 information), and they were used for the molecular docking simulations. 20 Despite the differences in the primary structure between the Homo sapiens δ-AlaD, 21 Dmδ-AlaD and Csδ-AlaD, the comparison of the tertiary structure of the three enzymes 22 exhibited a very similar organization of the residues, with the simulated PBG binding pose 23 presenting practically the same conformation and interactions (Figure 3) . Here, we highlighted 24 the major difference in the active site of both enzymes. As shown in Figure 3AB , in Hsδ-AlaD 25 and Dmδ-AlaD the thiolates of the Cys residues are coordinated to a zinc ion (Zn 2+ ), where this 26 metal nucleus acts as a Lewis acid and Zn … N coordination with the amino moiety (Lewis base) 27 from PBG is formed. This Zn … N interaction is essential to the catalysis of the δ-AlaD, because 28 it specifically guides one molecule of 5-Ala substrate in subsite A, before the cyclization to 29 pyrrole ring [86, 90] . In fact, the Cys mutations cause a dramatic reduction in the enzyme activity 30 [12] . On the other hand, according to the docking simulation between the PBG and Csδ-AlaD, 31 the orientation of one molecule of 5-Ala substrate is likely driven by the H-bonds between the 1 amino moiety from 5-Ala and the carboxylate groups of Asp217 and Asp225 residues ( Figure 2 3C). The PBG binding pose obtained by the docking in Csδ-AlaD is very similar to the 3 crystallographic data collected from T. gondii δ-AlaD [21] . Interestingly, Asp217 and Asp225 4 are the residues that correspond to Cys124 and Cys132 residues in the human enzyme, 5 respectively (Figure 2 and 3) . 6 In addition, in the case of Csδ-AlaD, the Mg 2+ ion is not present in the active site ( Figure 7 3C), and does not participate directly in the catalysis. However, the Mg 2+ is essential to enzyme 8 function, as observed in E. coli, Bradyrhizobium japonicum, Pseudomonas aeruginosa, and P. 9 sativum, due to the H-bonding network around this metal ion maintaining the quaternary 18 Molecular docking simulations were carried out to understand the δ-AlaD inhibition by 19 DPDS and PSA. According to the docking between the Hsδ-AlaD and DPDS, this latter interacts 20 with the enzyme active site mainly by hydrophobic interactions (π-π stacking with Phe79, 21 Tyr205 and Phe208 residues and alkyl-π with Pro125). The selenium atoms of DPDS interact 22 with the carboxylic group of Asp120 and with the Zn 2+ ion, besides the thiolate group from 23 Cys124 ( Figure 4A ). The putative DPDS metabolite, PSA, also interacts in the Hsδ-AlaD 24 active site, by π-π stacking with Tyr205 and Phe208, H-bond with Ser168, and interactions with 25 Tyr196 (anion-π interaction between the seleninate and the phenyl moieties), Asp120 (repulsive 26 electrostatic interaction between the seleninate and carboxyl groups), and zinc ion 27 (coordination). In addition, Se … S interaction with Cys124 is observed ( Figure 4B ). 28 The simulation of DPDS with the Dmδ-AlaD demonstrated that this organoselenium 29 compound could access the active site making hydrophobic interactions with Arg205, Pro212 (alkyl and phenyl groups), Phe204 and Tyr201 (phenyl and phenyl moieties), besides interacting 31 with Arg217 via H-bond (selenyl and guanidinyl groups [95,96]) ( Figure 4C ). In addition, the 1 DPDS showed a Se … S interaction with Cys122. The PSA molecule also binds in the Dmδ-AlaD 2 active site, through hydrophobic π-π stacking with Phe204 and Tyr201 (phenyl and phenyl 3 moieties), through H-bonds with Ser165, Lys195, and Gln221 (seleninate and OH, NH and C=O 4 groups, respectively), and Zn … O coordination. Similarly to DPDS, the PSA also showed Se … S 5 interaction with Cys122 ( Figure 4D ). 6 On the other hand, the docking simulations between the Csδ-AlaD and DPDS Lys313 (phenyl and carbon chain) and presenting an intramolecular π-π stacking (phenyl-10 phenyl) ( Figure 4E ). In contrast, PSA can access the active site of Csδ-AlaD ( Figure 4F ), 11 making H-bonds with Arg301 and Lys291 residues, stabilized by electrostatic interaction with 12 Asp217, and π-π stacking with Phe330 (phenyl and phenyl moieties). Finally, we simulated the interactions of other putative oxidized organoselenium forms 14 [97] ( Figure S5 ) to verify if these molecules are able to interact with the δ-AlaD enzymes, and The predicted binding free energy (ΔGbind) for the Hsδ-AlaD indicates that the 24 interaction of DPDS with the enzyme is energetically more favored than the interaction PSA-25 enzyme. (Table 1 ). In contrast, ΔGbind for Dmδ-AlaD suggests a more favorable PSA-enzyme (Figure 4A-D) . However, for Csδ-AlaD, only PSA binds in the active site, and no Se … S 2 interaction is present because the Csδ-AlaD does not have Cys residues in the active site ( Figure 3 4E-F). These outcomes strongly suggest that organoselenium compounds binding in the active 4 sites could prevent the entrance of the substrate 5-Ala, thus inhibiting the enzymes. The previous in vitro assays have indicated that the mechanism of Hsδ-AlaD (or 9 mammalian δ-AlaD) and Dmδ-AlaD inhibition by organoselenium compounds involves Cys 10 oxidation because dithiothreitol (DTTred) could reactivate the enzyme from these sources 11 [10, 11, 24, 29, 30, 98] . The Se … S interaction could lead to the formation of the selenenyl sulfide Csδ-AlaD has no Cys residues in the active site and consequently, the Cys oxidation 4 mechanism is not possible. PSA, likely due to its polarity, has a better affinity for the active 5 site of Csδ-AlaD (where polar and basic residues are present). PSA has a highly electrophilic 6 Se atom [30, 115, 116] . Its Hirshfeld partial charge is higher than the one computed for Se in 7 DPDS and in the other selenium compounds of this study, indicating a deficiency of electrons 8 ( Table S4 ). In addition, due to the short distance between the Se atom and the amino group from proximity to Arg301 ( Figure 4F) and because water is a better leaving group than hydroxyl 25 anion. Our results (Figure 5) indicate that the seleninamide formation is energetically favored, 26 both in the gas and water phase. The reactant complex (PhSeOOH·EtNH2) is characterized by 27 an H-bond between the hydroxyl and amino groups and by a short distance Se … N (3.8 Å), 28 promoting the release of a water molecule and the formation of the Se-N bond in the product 29 complex (PhSeONHEt·H2O) (Figure 5A) . 30 The proximity between electrophilic forms of organoselenium molecules and 1 nucleophilic moieties from critical amino acids residues (in this case Se … S/N interactions from 2 Cys124, Cys122, and Lys291, from Hsδ-AlaD, Dmδ-AlaD, and Csδ-AlaD, respectively) could 3 lead to covalent bonds formation, and consequently, these adducts can impair the functions of 4 enzymes, inhibiting them. This mechanism could justify the toxicity of some organoselenium 5 compounds. 6 The understanding of the mechanism of organoselenium compounds toxicity will be 7 crucial in the designing of new molecules less toxic and more selective in relation to 8 pharmacological targets. In this sense, the potential role of metabolites of a given drug can also 9 be informative, as suggested by our present study. Organoselenium molecules have promising properties (anxiolytic, antidepressant-like, anticancer, neuroprotective, and others) and its 16 mechanism of action involves the modulation of the cellular redox status [123] . DPDS could 17 modulate any protein having reactive thiol groups due to the lack of specific molecular targets. 18 In this way, new DPDS derivatives with higher selectivity for specific protein targets still need 19 to be developed. The present work, entirely performed in silico and combining multiscale approaches, 23 provides an efficient explanation to experimental in vitro data, giving evidence that DPDS 24 inhibits Hsδ-AlaD and Dmδ-AlaD enzymes, but does not inhibit Csδ-AlaD [11, 29, 30 ]. The Se … S interaction, which could lead to Cys oxidation, and, consequently, protein denaturation 3 and enzyme inhibition. This type of study is essential to understand the reactivity and selectivity 4 of organoselenium compounds in biological systems and can lead to better rational drug design. 5 On the basis of these promising computational results, further studies are prompted. In addition, 6 due to its protein similarity and organoselenium binding pose, Dmδ-AlaD rather than Hsδ-AlaD 7 could be used as a model to test the toxicity of new organoselenium molecules. 8 9 Conflicts of interest 10 The authors declare no conflicts of interest. 11 12 The Tables S1-S4, Figures S1-S8 , and the XYZ coordinates of the structures (Table S5) highlighted: Cys (yellow); residues that remain conserved (cyan), residues that are not 26 conserved when compared to the human enzyme (green and pink). The complete alignment is 27 shown in Figure S1 . Csδ-AlaD enzymes, respectively. (B, D, and F) PSA binding pose in Hsδ-AlaD, Dmδ-AlaD, 10 and Csδ-AlaD, respectively. H-bonds (green), hydrophobic (π-π, alkyl-π) (purple), cation-π, 11 anion-π, electrostatic interactions (orange), and zinc coordination (blue), are represented by 12 dotted lines; all the distances are in Å. The ligands and the amino acids lateral chains are 13 represented by ball and stick, and stick models, respectively. phase. PhSeOOH + EtNH2 and PhSeONHEt + H2O correspond to the reagents and products, 19 while PhSeOOH·EtNH2 and PhSeONHEt·H2O are the reactant and product complexes, 20 respectively. All energy values are relative to the free reactants. 21 22 Scheme S1. Overview of all the steps involved in this study. The Se … S/N interactions as a possible mechanism of δ-aminolevulinic acid 1 dehydratase enzyme inhibition by organoselenium compounds: a 2 computational study 3 4 Pablo Andrei Nogara a , Laura Orian b , and João Batista Teixeira Rocha a* Organoselenium compounds present many pharmacological properties and are 12 promising drugs. However, toxicological effects associated with inhibition of thiol-containing 13 enzymes, such as the δ-aminolevulinic acid dehydratase (δ-AlaD), have been described. The 14 molecular mechanism(s) by which they inhibit thiol-containing enzymes at the atomic level, is 15 still not well known. The use of computational methods to understand the physical-chemical 16 properties and biological activity of chemicals is essential to the rational design of new drugs. 17 In this work, we propose an in silico study to understand the δ-AlaD inhibition mechanism by 18 diphenyl diselenide (DPDS) and its putative metabolite, phenylseleninic acid (PSA), using δ- 19 AlaD enzymes from Homo sapiens (Hsδ-AlaD), Drosophila melanogaster (Dmδ-AlaD) and 20 Cucumis sativus (Csδ-AlaD). Protein modeling homology, molecular docking, and DFT Inhibition of thioredoxin reductase by a novel series of bis-1,2-benzisoselenazol-3(2H)-15 ones: Organoselenium compounds for cancer therapy Silico Studies of Mammalian δ-ALAD Interactions with 18 Selenides and Selenoxides Organochalcogen peroxidase mimetics as potential drugs: A long 21 story of a promise still unfulfilled, Free Radic AutoDock4 and AutoDockTools4: Automated Docking with Selective Receptor 7 AutoDock Vina: Improving the Speed and Accuracy of Docking 9 with a New Scoring Function, Efficient Optimization, and Multithreading Cross-docking study on 12 InhA inhibitors: A combination of Autodock Vina and PM6-DH2 simulations to 13 retrieve bio-active conformations Identification of new potential Mycobacterium 16 tuberculosis shikimate kinase inhibitors through molecular docking simulations 22 adiabatic connection methods without adjustable parameters: The mPW and mPW1PW Gaussian Basis Functions for Use in Molecular Calculations . IV . The 3 Representation of Polarization Functions for the First Row Atoms and Hydrogen Modeling the Mechanism of the Glutathione Peroxidase Mimic 6 Mechanistic 10 basis for suicide inactivation of porphobilinogen synthase by 4,7-Dioxosebacic acid, an 11 inhibitor that shows dramatic species selectivity Drug Discovery : Current Perspectives Modelling three-dimensional protein structures 16 for applications in drug design Advances in Homology Protein Structure Modeling Computational insights into 21 the mechanism of porphobilinogen synthase The Heme Biosynthetic Pathway of the Obligate Wolbachia 2 Endosymbiont of Brugia malayi as a Potential Anti-filarial Drug Target In silico designing and molecular 6 docking of a potent analog against Staphylococcus aureus porphobilinogen synthase The nature of selenium 9 hydrogen bonding: Gas phase spectroscopy and quantum chemistry calculations Spectroscopic Evidences for Strong Hydrogen Bonds with 13 Selenomethionine in Proteins Mechanistic Insight into the Oxidation of Organic Phenylselenides 17 by H2O2, Chem. -A Eur Interaction of metals 20 from group 10 (Ni, Pd, and Pt) and 11 (Cu, Ag, and Au) with human blood δ-ALA-D: 21 in vitro and in silico studies Chalcogen bonding interactions between reducible sulfur and 24 selenium compounds and models of zinc finger proteins Key steps and intermediates in the catalytic mechanism for the 27 reduction of peroxides by the antioxidant ebselen Biohybrid-Se-S-coupling reactions of an amino acid 30 derived seleninate Thiol/Diselenide Exchange for the Generation of 2 Catalytic Reductive Ring-Opening of α,β-Epoxy Ketoness Pharmacology and 5 toxicology of diphenyl diselenide in several biological models Launched Reduction-Responsive Superparamagnetic Nanogel Combined of Acid Responsiveness for Achievement of Efficient Therapy with Low Side Effect Cysteine-Specific PEGylation of rhG-CSF via 14 Selenium and sulfur in exchange reactions: 17 A comparative study Addition-Elimination or 20 Nucleophilic Substitution? Understanding the Energy Profiles for the Reaction of 21 Oxidation-Reduction Reactions of Organoselenium Compounds Mechanism of the Reaction between Seleninic Acids and Thiols Stable selones in glutathione-peroxidase-like catalytic cycle of 28 selenonicotinamide derivative Antioxidant Activity of the Anti-Inflammatory Compound 31 Ebselen: A Reversible Cyclization Pathway via Selenenic and Seleninic Acid 1 Mechanism of the reaction of 4 ebselen with endogenous thiols: dihydrolipoate is a better cofactor than glutathione in 5 the peroxidase activity of ebselen Interaction profile of diphenyl diselenide with 7 pharmacologically significant thiols Ebselen as a potent covalent inhibitor of New Delhi metallo-β-lactamase 11 (NDM-1) Molecular Docking Studies of 13 Disubstituted Diaryl Diselenides as Mammalian δ -Aminolevulinic Acid Dehydratase 14 Why Nature Chose Selenium Electrophilic Selenium/Tellurium Reagents: Reactivity and their 19 Contribution to Green Chemistry Synthesis and glutathione peroxidase-like 22 activities of isoselenazolines A novel camphor-derived selenamide that acts as a glutathione 25 peroxidase mimetic Organoselenium Chemistry. Redox Chemistry of 28 A safe lithium mimetic 1 for bipolar disorder Structure of Mpro from COVID-19 virus and discovery of its inhibitors Revitalizing the 10 AZT Through of the Selenium: An Approach in Human Triple Negative Breast Cancer Chemistry and pharmacology of synthetic 13 organoselenium compounds The Se … S/N interactions as a possible mechanism of δ-aminolevulinic acid 2 dehydratase enzyme inhibition by organoselenium compounds: a 3 computational study 4 5 Pablo Andrei Nogara a , Laura Orian b , and João Batista Teixeira Rocha a* Dear Editor Dr Cronin, 4 5 We declare that all the authors contributed substantially to the design and implementation of the 6 research, to the analysis of the results and to the writing of the manuscript.